MedWatch

Regulation

EU to investigate container rates – expects results by New Year's

In the wake of towering freight rates and massive delays, the European Commission has commenced an investigation of liner companies’ special exemption from the union’s competition rules. Industry players will have the opportunity to submit documents ”relevant to the evaluation,” spokesperson says.

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Danish Medicines Council makes five recommendations after April meeting

The council has processed five drug applications at this month’s meeting, including proposals from Bristol Meyers Squibb and Novartis, which received thumbs-up for treatments for cancer and spinal arthritis, respectively. Sanofi’s application was rejected and Merck/Pfizer’s combination pitch was not approved, despite new data.

EMA management board elects new chair

The European Medicines Agency’s management board has found a new chair in the chief executive of the Irish health authority, Lorraine Nolan. With Emer Cooke, executive director at the EMA, there are now two women guiding the European agency.

1 - 25 of 168

Latest news

See all jobs